Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

50%

2 trials in Phase 3/4

Results Transparency

33%

1 of 3 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A

1(33.3%)

Phase 4

1(33.3%)

Phase 3

1(33.3%)

3Total

N/A(1)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials

NCT04002791Not ApplicableCompleted

Patent Hemostasis With Vasoband Versus TR Band

Role: lead

NCT01564888Phase 4Completed

Prevention of Radial Artery Occlusion: Prophylactic Hyperperfusion Evaluation Trial

Role: lead

NCT02413268Phase 3Unknown

Topical Nitroglycerin To Prevent Radial Artery Occlusion After Transradial Access: NTP-RAO Trial

Role: lead

NCT01677481Completed

Randomized Evaluation of Vascular Entry Site and Radiation Exposure: REVERE Trial

Role: lead

All 4 trials loaded